Development and validation of LC/MS/MS method for the simultaneous determination of montelukast, gliclazide, and nifedipine and its application to a pharmacokinetic study

BACKGROUND: Montelukast is a leukotriene receptor antagonist for treatment of asthma, gliclazide is an oral hypoglycemic antidiabetic agent, and nifedipine is a calcium channel blocker used for treatment of angina pectoris and hypertension. These drugs may be prescribed to patients suffering from th...

Descripción completa

Detalles Bibliográficos
Autores principales: Ezzeldin, Essam, Abo-Talib, Nisreen F, Tammam, Marwa H, Shahat, Abdelaaty A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3984717/
https://www.ncbi.nlm.nih.gov/pubmed/24618480
http://dx.doi.org/10.1186/1752-153X-8-17

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3984717/
https://www.ncbi.nlm.nih.gov/pubmed/24618480
http://dx.doi.org/10.1186/1752-153X-8-17

Ejemplares similares